Skip to main content
Caplight Logo









Tellescope

Tellescope

Private
Jersey City, New JerseyHealthcare & Life Scienceshttps://www.tellescope.com/

Last Round

Early Funding

Jan 1, 2022

Total Funding Raised

$120,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Tellescope is a digital health company that provides a HIPAA-compliant patient relationship management platform for digital health startups and clinics to streamline patient engagement and care operations.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, EHR & EMR, Workflow Automation, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Usage-Based SaaS

AI Layer

Application

Keywords

patient engagementhealthcare CRMworkflow automationelectronic health recordEHRtelemedicine platformpatient intakehealthcare APIdigital healthvertical SaaSAI agent orchestrationpatient communicationclinical workflowhealthtechpatient portal

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tellescope Comparables

Compare Tellescope with similar companies based on industry and business-model similarity.

Tellescope comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
OhMD
83%
Spruce Health
81%
Healee
81%

Tellescope Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJan 1, 2022
AcceleratorAug 31, 2020

Key People

Founding team and executive leadership

Derek Strauss

Co-Founder, COO

Founding Team

Sebastian Coates

CEO Co-founder

Founding Team

Tellescope Investors

Notable investors and investment history

Tellescope investors
InvestorRounds
TechstarsAccelerator
UnitedHealthcare AcceleratorAccelerator
StartUp HealthEarly Funding, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 18, 2026

    Grew 25% QoQ, from 12 to 15 employees.

  • Dec 8, 2025

    Monthly visitors grew 69% MoM, reaching 234.6K.

Tellescope Filings

Explore SEC and related filing metadata, where available.

Tellescope filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Tellescope's valuation, stock price, and market status.

Is Tellescope a public or private company?

Tellescope is a private company.

What is the current stock price of Tellescope?

Tellescope is a private company with no public stock price. No recent secondary market data is available.

How much is Tellescope worth (valuation)?

Valuation information for Tellescope is not publicly available.

Can I buy Tellescope stock?

Tellescope shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Tellescope's last funding round?

Tellescope's most recent funding round was Early Funding on January 1, 2022.

Who are the main investors in Tellescope?

Key investors in Tellescope include Techstars, UnitedHealthcare Accelerator, StartUp Health.

Will Tellescope IPO soon?

No public IPO plans have been announced for Tellescope.

How can I track Tellescope secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tellescope's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersJersey City, New Jersey
Employee Range10
Year Founded2020
Last FundingJan 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?